Acknowledgements

We thank all the patients who participated in the MedBridge trial, and Christine Jonsson and Marika Callmar for their help with data analysis. We would like to acknowledge the other MedBridge research group members: Maria Bertilsson, Johanna Carlsson and Åke Tenerz. This study was part of the MedBridge project, which has received governmental research grants RFR-555601, RFR-641791, and RFR-735911 from the Uppsala-Örebro Regional Research Council, grants LUL-527721, LUL-614061, LUL-716201, and LUL-821261 from Region Uppsala, grants CFUG-658451 and CFUG-698771 from Region Gävleborg, and grants LTV-675921, LTV-712341, LTV-736641, and LTV-840112 from Region Västmanland, funding from the Swedish Pharmacists Association (Sveriges Farmaceuter), the Thuréus Fund for Geriatric Research (Thuréus stiftelse för främjande av geriatrisk forskning) and the Geriatric Fund (Geriatriska fonden) and grants FA2017:38 and FA2018:43 from the Swedish Heart and Lung Association (Riksförbundet HjärtLung).